These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15078250)

  • 41. Creutzfeldt-Jakob disease.
    Tyler KL
    N Engl J Med; 2003 Feb; 348(8):681-2. PubMed ID: 12594311
    [No Abstract]   [Full Text] [Related]  

  • 42. Implications of CJD data need to be clear before release.
    Thornett A
    BMJ; 2000 Sep; 321(7262):701. PubMed ID: 11202929
    [No Abstract]   [Full Text] [Related]  

  • 43. Leucoreduction and variant Creutzfeldt-Jakob disease.
    Darabi K; Dzik WH; Stowell CP; Saito Y
    Transfus Med; 2005 Aug; 15(4):335. PubMed ID: 16101813
    [No Abstract]   [Full Text] [Related]  

  • 44. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
    Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
    Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
    Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
    Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progress towards a blood test for vCJD?
    Anstee DJ
    Vox Sang; 2002 Aug; 83 Suppl 1():203-5. PubMed ID: 12617138
    [No Abstract]   [Full Text] [Related]  

  • 47. Tissue classification for the epidemiological assessment of surgical transmission of sporadic Creutzfeldt-Jakob disease. A proposal on hypothetical risk levels.
    Rábano A; de Pedro-Cuesta J; Mølbak K; Siden A; Calero M; Laursen H;
    BMC Public Health; 2005 Jan; 5():9. PubMed ID: 15667663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
    Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
    Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum. Appropriate study populations must be used.
    McConville JP; Craig JJ
    BMJ; 1998 Aug; 317(7156):472; author reply 472-3. PubMed ID: 9703539
    [No Abstract]   [Full Text] [Related]  

  • 51. Consensus conference on vCJD screening of blood donors: report of the panel.
    McCullough J; Anderson D; Brookie D; Bouchard JP; Fergusson D; Joly J; Kenny N; Lee D; Megânn H; Page D; Reinharz D; Williams JR; Wilson K
    Transfusion; 2004 May; 44(5):675-83. PubMed ID: 15104647
    [No Abstract]   [Full Text] [Related]  

  • 52. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA; Turner ML
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The mystery of prion proteins: from neurodegenerative diseases to the biology of reproduction].
    Peoc'h K
    Ann Biol Clin (Paris); 2005; 63(2):121-6. PubMed ID: 15771969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Future uncertain for reliable vCJD screening tests.
    Bonn D
    Lancet; 2000 Jul; 356(9225):228. PubMed ID: 10963208
    [No Abstract]   [Full Text] [Related]  

  • 55. Amplification of Misfolded Prion Proteins in Blood and Cerebrospinal Fluid for Detection of Creutzfeldt-Jakob Disease.
    DeMarco ML
    Clin Chem; 2017 Nov; 63(11):1671-1673. PubMed ID: 28724625
    [No Abstract]   [Full Text] [Related]  

  • 56. Prions and blood transfusion.
    Barbara J
    Transfus Sci; 2000; 22(1-2):49. PubMed ID: 10771380
    [No Abstract]   [Full Text] [Related]  

  • 57. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 58. [Creutzfeldt-Jakob disease and transfusion].
    Saura C
    Ann Biol Clin (Paris); 2001 Oct; 59 Spec No():23-4. PubMed ID: 11675288
    [No Abstract]   [Full Text] [Related]  

  • 59. The quandary of Creutzfeldt-Jakob disease.
    Larke B
    CMAJ; 1998 Oct; 159(7):789-92. PubMed ID: 9805025
    [No Abstract]   [Full Text] [Related]  

  • 60. B cells may propagate prions.
    Vogel G
    Science; 1997 Dec; 278(5346):2050. PubMed ID: 9432715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.